2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and mana...
2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and management
About this item
Full title
Author / Creator
Publisher
Kidlington: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Introduction/BackgroundEndometrioid Borderline Ovarian Tumor (EBOT) is a rare subtype of borderline ovarian malignancies. This study aimed to determine the prognosis of a series of EBOT.MethodologyA retrospective review of patients with EBOT treated in or referred to our institutions. A centralized histological review by a reference pathologist; da...
Alternative Titles
Full title
2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and management
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2728833533
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2728833533
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2022-ESGO.480
